These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
615 related articles for article (PubMed ID: 29168357)
21. S100A12 Is Associated with Response to Therapy in Juvenile Idiopathic Arthritis. Gohar F; Anink J; Moncrieffe H; Van Suijlekom-Smit LWA; Prince FHM; van Rossum MAJ; Dolman KM; Hoppenreijs EPAH; Ten Cate R; Ursu S; Wedderburn LR; Horneff G; Frosch M; Foell D; Holzinger D J Rheumatol; 2018 Apr; 45(4):547-554. PubMed ID: 29335345 [TBL] [Abstract][Full Text] [Related]
22. Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry Seven-Year Interim Results. Brunner HI; Nanda K; Toth M; Foeldvari I; Bohnsack J; Milojevic D; Rabinovich CE; Kingsbury DJ; Marzan K; Chalom E; Horneff G; Kuester RM; Dare JA; Trachana M; Jung LK; Olson J; Minden K; Quartier P; Bereswill M; Kalabic J; Kupper H; Lovell DJ; Martini A; Ruperto N; Arthritis Care Res (Hoboken); 2020 Oct; 72(10):1420-1430. PubMed ID: 31421019 [TBL] [Abstract][Full Text] [Related]
23. A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study. Hissink Muller PC; Brinkman DM; Schonenberg D; Koopman-Keemink Y; Brederije IC; Bekkering WP; Kuijpers TW; van Rossum MA; van Suijlekom-Smit LW; van den Berg JM; Allaart CF; Ten Cate R Pediatr Rheumatol Online J; 2017 Feb; 15(1):11. PubMed ID: 28166785 [TBL] [Abstract][Full Text] [Related]
24. Switched Memory B Cells Are Increased in Oligoarticular and Polyarticular Juvenile Idiopathic Arthritis and Their Change Over Time Is Related to Response to Tumor Necrosis Factor Inhibitors. Marasco E; Aquilani A; Cascioli S; Moneta GM; Caiello I; Farroni C; Giorda E; D'Oria V; Marafon DP; Magni-Manzoni S; Carsetti R; De Benedetti F Arthritis Rheumatol; 2018 Apr; 70(4):606-615. PubMed ID: 29316374 [TBL] [Abstract][Full Text] [Related]
25. Health-related quality of life during early aggressive treatment in patients with polyarticular juvenile idiopathic arthritis: results from randomized controlled trial. Tarkiainen M; Tynjälä P; Vähäsalo P; Kröger L; Aalto K; Lahdenne P Pediatr Rheumatol Online J; 2019 Dec; 17(1):80. PubMed ID: 31842940 [TBL] [Abstract][Full Text] [Related]
26. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis. Albers HM; Wessels JA; van der Straaten RJ; Brinkman DM; Suijlekom-Smit LW; Kamphuis SS; Girschick HJ; Wouters C; Schilham MW; le Cessie S; Huizinga TW; Ten Cate R; Guchelaar HJ Arthritis Rheum; 2009 Jan; 61(1):46-51. PubMed ID: 19116975 [TBL] [Abstract][Full Text] [Related]
27. [Personal experience with methotrexate in the treatment of idiopathic juvenile arthritis]. Tambić-Bukovac L; Malcić I; Prohić A Reumatizam; 2002; 49(1):20-4. PubMed ID: 12476749 [TBL] [Abstract][Full Text] [Related]
28. Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial. van Dijk BT; Bergstra SA; van den Berg JM; Schonenberg-Meinema D; van Suijlekom-Smit LWA; van Rossum MAJ; Koopman-Keemink Y; Ten Cate R; Allaart CF; Brinkman DMC; Hissink Muller PCE Pediatr Rheumatol Online J; 2024 May; 22(1):53. PubMed ID: 38730442 [TBL] [Abstract][Full Text] [Related]
29. Decreasing trend in the incidence of serious pneumonias in Finnish children with juvenile idiopathic arthritis. Salonen PH; Salonen JH; Säilä H; Helminen M; Linna M; Kauppi MJ Clin Rheumatol; 2020 Mar; 39(3):853-860. PubMed ID: 31732822 [TBL] [Abstract][Full Text] [Related]
30. A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial). Ramanan AV; Dick AD; Benton D; Compeyrot-Lacassagne S; Dawoud D; Hardwick B; Hickey H; Hughes D; Jones A; Woo P; Edelsten C; Beresford MW; Trials; 2014 Jan; 15():14. PubMed ID: 24405833 [TBL] [Abstract][Full Text] [Related]
31. Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis. Zajc Avramovič M; Dolžan V; Toplak N; Accetto M; Lusa L; Avčin T J Rheumatol; 2017 Aug; 44(8):1216-1223. PubMed ID: 28572465 [TBL] [Abstract][Full Text] [Related]
32. Methotrexate polyglutamates as a potential marker of adherence to long-term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: an observational, cross-sectional study. Hawwa AF; AlBawab A; Rooney M; Wedderburn LR; Beresford MW; McElnay JC Arthritis Res Ther; 2015 Oct; 17():295. PubMed ID: 26493320 [TBL] [Abstract][Full Text] [Related]
33. Trends towards more active introduction of drug therapy, emphasizing methotrexate and biologic agents, for juvenile idiopathic arthritis. Pohjankoski H; Kautiainen H; Lauri JV; Puolakka K; Rantalaiho V Clin Rheumatol; 2020 Jan; 39(1):263-268. PubMed ID: 31346886 [TBL] [Abstract][Full Text] [Related]
34. Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis. Hinks A; Moncrieffe H; Martin P; Ursu S; Lal S; Kassoumeri L; Weiler T; Glass DN; Thompson SD; Wedderburn LR; Thomson W Ann Rheum Dis; 2011 Aug; 70(8):1395-400. PubMed ID: 21515602 [TBL] [Abstract][Full Text] [Related]
35. The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate. Alsufyani K; Ortiz-Alvarez O; Cabral DA; Tucker LB; Petty RE; Malleson PN J Rheumatol; 2004 Jan; 31(1):179-82. PubMed ID: 14705239 [TBL] [Abstract][Full Text] [Related]
36. Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexate. Lovell DJ; Brunner HI; Reiff AO; Jung L; Jarosova K; Němcová D; Mouy R; Sandborg C; Bohnsack JF; Elewaut D; Gabriel C; Higgins G; Kone-Paut I; Jones OY; Vargová V; Chalom E; Wouters C; Lagunes I; Song Y; Martini A; Ruperto N RMD Open; 2020 Jul; 6(2):. PubMed ID: 32665432 [TBL] [Abstract][Full Text] [Related]
37. Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay. Möhlmann JE; de Roock S; Egas AC; Weijden ET; Doeleman MJH; Huitema ADR; van Luin M; Swart JF Pediatr Rheumatol Online J; 2024 May; 22(1):52. PubMed ID: 38715014 [TBL] [Abstract][Full Text] [Related]
38. Leflunomide is associated with a higher flare rate compared to methotrexate in the treatment of chronic uveitis in juvenile idiopathic arthritis. Bichler J; Benseler SM; Krumrey-Langkammerer M; Haas JP; Hügle B Scand J Rheumatol; 2015; 44(4):280-3. PubMed ID: 25993023 [TBL] [Abstract][Full Text] [Related]
39. Abatacept as Monotherapy and in Combination With Methotrexate in Patients With Juvenile Idiopathic Arthritis: Analysis of 2 Phase III Trials. Ruperto N; Lovell DJ; Berman A; Anton J; Viola DO; Lauwerys B; Rama ME; Bohnsack J; Breedt J; Fischbach M; Lutz T; Minden K; Ally M; Rubio-Pérez N; Gervais E; Van Zyl R; Wong R; Askelson M; Martini A; Brunner HI; J Rheumatol; 2023 Nov; 50(11):1471-1480. PubMed ID: 37453737 [TBL] [Abstract][Full Text] [Related]
40. Time spent in inactive disease before MTX withdrawal is relevant with regard to the flare risk in patients with JIA. Klotsche J; Minden K; Niewerth M; Horneff G Ann Rheum Dis; 2018 Jul; 77(7):996-1002. PubMed ID: 29453217 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]